Other terms
Anticancer Drug Sensitivity Tests,Cancer Drug Tests,Cancer Drug Test,Drug Test, Cancer,Drug Tests, Cancer,Test, Cancer Drug,Tests, Cancer Drug,Antitumor Drug Screens,Antitumor Drug Screen,Drug Screen, Antitumor,Drug Screens, Antitumor,Screen, Antitumor Drug,Screens, Antitumor Drug,Drug Screening Tests, Tumor-Specific,Drug Screening Tests, Tumor Specific,Tumor-Specific Drug Screening Tests,Tumor Specific Drug Screening Tests,Anti-Cancer Drug Screens,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Drug Screen, Anti-Cancer,Drug Screens, Anti-Cancer,Screen, Anti-Cancer Drug,Screens, Anti-Cancer Drug,Antitumor Drug Screening Assays,Dye Exclusion Assays, Antitumor
Description
Drug Screening Assays, Antitumor: Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals.
Pervious tree
Next tree
Other locations in tree
Legal notice
The U.S. National Library of Medicine is the creator, maintainer, and provider of the data above.
The version of the data is 2010 MeSH. Last reviewed April 26, 2010. No modification has been made in the content of the file.
Neither the United States Government, nor any of its agencies, contractors, subcontractors or employees makes any warranties, expressed or implied, with respect to data contained in the database, and, furthermore, assumes no legal liability for any party's use, or the results of such use, of any part of the database.
You will not assert any proprietary rights to any portion of the database, or represent the database or any part thereof to anyone as other than a United States Government database.
The MeSH data carry an international copyright outside the United States, its Territories or Possessions. These terms and conditions are in effect as long as the user retains any of the MeSH data obtained from this site.